Xtl Biopharmaceuticals XTLB
NASDAQ XTLB
$2.16 +0.03 (+1.41%)
As of: Oct 2, 2026 · 1:58 PM EDT

Xtl Biopharmaceuticals (XTLB) Price to Sales (2012 - 2024)

Updated

Xtl Biopharmaceuticals' Price to Sales was 4744.03 in the quarter ended Dec 31, 2024.

Analysis

Xtl Biopharmaceuticals (XTLB) Price to Sales (2012 - 2024) Analysis & Trends

For the year ended Dec 31, 2024, Price to Sales at Xtl Biopharmaceuticals came in at 3029.45.

  • In earlier years, Price to Sales was 141640.32 in the year ended Dec 31, 2020.
  • The figure for the quarter ended Dec 31, 2024 marks the highest quarterly Price to Sales since the quarter ended Mar 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Xtl Biopharmaceuticals 2.27 Bn 2.27 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 4,744.03
Mar 31, 2022 215,237.92
Mar 31, 2021 5,726.77
Dec 31, 2020 2,271.20
Mar 31, 2020 481.18
Sep 30, 2014 193.45
Jun 30, 2014 318.10
Mar 31, 2014 356.51
Dec 31, 2013 273.73
Sep 30, 2013 515.00
Jun 30, 2013 608.06
Mar 31, 2013 637.02
Dec 31, 2012 754.09
Sep 30, 2012 583.98
Jun 30, 2012 482.68
Mar 31, 2012 386.98
API Access

Xtl Biopharmaceuticals Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=XTLB&period=max&api_key=YOUR_API_KEY